Chaudhary, P., Guragain, D., Chang, J., & Kim, J. (2021). TPH1 and 5-HT<sub>7</sub> Receptor Overexpression Leading to Gemcitabine-Resistance Requires Non-Canonical Permissive Action of EZH2 in Pancreatic Ductal Adenocarcinoma. MDPI AG.
Style de citation Chicago (17e éd.)Chaudhary, Prakash, Diwakar Guragain, Jae-Hoon Chang, et Jung-Ae Kim. TPH1 and 5-HT<sub>7</sub> Receptor Overexpression Leading to Gemcitabine-Resistance Requires Non-Canonical Permissive Action of EZH2 in Pancreatic Ductal Adenocarcinoma. MDPI AG, 2021.
Style de citation MLA (8e éd.)Chaudhary, Prakash, et al. TPH1 and 5-HT<sub>7</sub> Receptor Overexpression Leading to Gemcitabine-Resistance Requires Non-Canonical Permissive Action of EZH2 in Pancreatic Ductal Adenocarcinoma. MDPI AG, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.